Results 221 to 230 of about 57,323 (255)

Irinotecan

Reactions Weekly, 2012
openaire   +2 more sources

Whither Irinotecan?

Journal of Clinical Oncology, 2005
openaire   +2 more sources

Irinotecan

Reactions Weekly, 2003
openaire   +3 more sources

Irinotecan

Reactions Weekly, 2005
openaire   +1 more source

Phase II/III study of second-line chemotherapy comparing irinotecan-alone with S-1 plus irinotecan in advanced gastric cancer refractory to first-line treatment with S-1 (JACCRO GC-05)

Annals of Oncology, 2015
M Kochi, Y Kakeji, N Matsuhashi
exaly  

A randomized phase II study of PEP02 (MM-398), irinotecan or docetaxel as a second-line therapy in patients with locally advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma†

Annals of Oncology, 2013
David Cunningham, Josep Tabernero Caturla, S R Park   +2 more
exaly  

Irinotecan

Reactions Weekly, 2008
openaire   +1 more source

Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study

Annals of Oncology, 2004
Johannes Bükki, V Gorbunova, C Peschel
exaly  

Efficacy of FOLFIRI-3 (irinotecan D1,D3 combined with LV5-FU) or other irinotecan-based regimens in oxaliplatin-pretreated metastatic colorectal cancer in the GERCOR OPTIMOX1 study

Annals of Oncology, 2009
C Louvet, G Lledo, A Figer
exaly  

Multicentre phase II study and pharmacokinetic analysis of irinotecan in chemotherapy-naïve patients with glioblastoma

Annals of Oncology, 2003
V Boige, O Rixe, M Fabbro
exaly